
Saturday, March 12, 2022 5:19:10 AM
Coronavirus was officially declared a pandemic two years ago today (11 March 2020). Ironically today marks the day that Pfizer has been delisted from the New York Stock Exchange.
Pfizer filed a Form 25 (https://www.sec.gov/Archives/edgar/data/78003/000087666122000258/xslF25X02/primary_doc.xml)?? on 7 March, 2022 with the Securities and Exchange Commission (SEC). The form was a request to delist their securities from the New York Stock Exchange (NYSE) and to exit the public market. The Nasdaq delisting notice indicates that the company's last trading day was yesterday (10 March 2022).
A Pfizer spokesperson confirmed the news today, saying: "On March 7, 2022, the New York Stock Exchange (NYSE) filed a Form 25 (Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934) related to the delisting of Pfizer’s 0.250% Notes due 2022.
"The 0.250% Notes due 2022 were euro-denominated notes that were paid in full on March 7, 2022 in accordance with their terms and maturity date. As a result, the 0.250% Notes due 2022 are no longer outstanding and thus are delisted from the NYSE. Pfizer’s Common Stock, $.05 par value (“PFE”) and Pfizer’s 1.000% Notes due 2027 (“PFE27”) continue to be listed on the New York Stock Exchange."
The Pfizer spokesperson provided no further commentary.
Court-mandated Pfizer documents unsealed
The news comes on the back of a stormy week in which court-mandated documents are being released by the FDA pertaining to its review of the clinical trials in support of Pfizer/BioNTech's Covid-19 vaccine license.
The court order will see 55,000 pages of Pfizer data released per month that was used to authorise their Covid-19 vaccine produced with BioNTech. BioNTech is a German biotechnology company based in Mainz with a branch in Cape Town, South Africa (https://www.radbiontech.com/)?? - that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.
Both Pfizer (an American company) and BioNTech (a German company) were producing the Pfizer-BioNTech Cominarty Covid-19 vaccine. The documents under contention show 1291 listed adverse events linked to the Pfizer-BioNTech vaccine.
It is unclear whether the de-listed Pfizer will be acquired by BioNTech, and if so what formula will be used to fill the Covid-19 vaccines distributed by BioNTech going forward, and whether BioNTech will be supplying South Africans with Covid-19 vaccines.
ANYTHING CAN HAPPEN TO YOUR INVESTMENTS PLEASE DO YOUR DD BEFORE INVESTING AND MAKE $$$$$$$
Recent PFE News
- Trending: Pfizer Obesity Drug Shows Mixed Study Results; Trial Discontinued • Dow Jones News • 12/01/2023 03:29:00 PM
- Pfizer Down Over 6%, on Track for Lowest Close Since March 2020 -- Data Talk • Dow Jones News • 12/01/2023 03:25:00 PM
- Pfizer's Planned Obesity Pill Shows Mixed Study Results • Dow Jones News • 12/01/2023 12:29:00 PM
- Pfizer Announces Topline Phase 2b Results of Oral GLP-1R Agonist, Danuglipron, in Adults with Obesity • Business Wire • 12/01/2023 11:45:00 AM
- Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 11/28/2023 10:05:13 PM
- Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference • Business Wire • 11/21/2023 03:00:00 PM
- Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting • PR Newswire (US) • 11/17/2023 03:33:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/16/2023 11:23:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/16/2023 11:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/16/2023 11:22:39 PM
- Pfizer to Stop Some Operations at Sandwich, UK Site; 500 Jobs Affected • Dow Jones News • 11/15/2023 09:45:00 AM
- Pfizer to Close UK Site With 500 Job losses, Sky News Reports • Dow Jones News • 11/15/2023 07:13:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:00:02 PM
- Pfizer to Relocate 781 Workers as It Closes New Jersey Facility • Dow Jones News • 11/07/2023 05:41:00 PM
- Pfizer to Lay Off 781 Workers in New Jersey • Dow Jones News • 11/06/2023 10:40:00 PM
- Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual Meeting • Business Wire • 11/02/2023 02:52:00 PM
- Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference • Business Wire • 11/02/2023 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2023 10:19:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2023 10:19:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2023 10:18:57 PM
- Trending: Pfizer 3Q Revenue Down 42% • Dow Jones News • 10/31/2023 07:48:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 12:04:50 PM
- Pfizer Swings to Q3 Adjusted Loss, Revenue Falls • IH Market News • 10/31/2023 11:41:09 AM
- Tuesday’s Wall Street Highlights: Pinterest, BP, Wolfspeed, Arista, Lattice, Pfizer and more • IH Market News • 10/31/2023 11:24:04 AM
- Pfizer Reports Third-Quarter 2023 Results • Business Wire • 10/31/2023 10:45:00 AM
POET Technologies Announces Pricing of US$1.4 Million Underwritten Public Offering of Common Shares and Warrants • POET • Dec 1, 2023 10:17 AM
CGrowth Capital Inc. Sets Stage for Exciting 2024 with Savage Barbell Apparel Expansion • CGRA • Nov 28, 2023 11:15 AM
Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing • IMMX • Nov 28, 2023 10:48 AM
Swifty Global Secures GLI Certification for New Cutting-Edge B2B Gaming Platform • DRCR • Nov 28, 2023 9:15 AM
Nate's Food Co. Successfully Obtains GACC Registration in China, Paving the Way for Contract Execution on Commodities • NHMD • Nov 28, 2023 8:00 AM
Mass Megawatts Announces LOWEST PRICE GUARANTEE on Solar Project Sales and Further Cost Reductions Using our Patent Pending Technologies • MMMW • Nov 28, 2023 8:00 AM